<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03323892</url>
  </required_header>
  <id_info>
    <org_study_id>2017/271</org_study_id>
    <nct_id>NCT03323892</nct_id>
  </id_info>
  <brief_title>Effect of Abstinence Duration on Embryo Development</brief_title>
  <official_title>Effect of Abstinence Duration on Embryo Development: a Prospective Sibling Oocyte Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim the investigators study is to analyze the embryo development if oocytes of the
      participants are injected with sperm from a longer or shorter (2 hours) abstinence duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants undergoing an IVF treatment, are asked to respect an abstinence duration of 2-7
      days. This is to obtain a sufficient number of motile sperm. A recent investigation, analyzed
      the quality (number and motility) of a sperm sample produced after an abstinence duration of
      4 to 7 days, followed by a second sperm sample 2 hours later. The second sample (after 2
      hours) was able to produce sperm cells with a higher motility. Not only has this short
      abstinence duration of 2 hours a positive effect on the motility, it will also reduce the
      sperm DNA damage, which again has a positive effect on embryo development. Because
      participants need gametes of high quality to obtain embryos with a high quality, the
      investigators want to investigate what the effect is of abstinence duration on embryo
      development.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>a prospective sibling oocyte study: both study arms will be applied to the oocytes of 1 patient</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Embryo development (blastocyst stage)</measure>
    <time_frame>1 year</time_frame>
    <description>embryo development 5/6 of the preimplantation development</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Embryo development (cleavage stage)</measure>
    <time_frame>1 year</time_frame>
    <description>embryo development on day 3 of the preimplantation development</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fertilization</measure>
    <time_frame>1 year</time_frame>
    <description>number of fertilized oocytes per number of mature oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utilization rate</measure>
    <time_frame>1 year</time_frame>
    <description>number of embryos used for transfer + cryopreserved for the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm quality</measure>
    <time_frame>1 year</time_frame>
    <description>concentration and motility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm DNA fragmentation</measure>
    <time_frame>1 year</time_frame>
    <description>analysis of non-viable sperm in the two samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Pregnancies</measure>
    <time_frame>1 year</time_frame>
    <description>pregnancies with a fetal heart beat</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Embryo Development</condition>
  <arm_group>
    <arm_group_label>'normal' abstinence duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients follow the normal abstinence duration as asked by the physician (2-7 days). This sperm will be used to inject half of the oocytes Intervention = second sperm sample</description>
  </arm_group>
  <arm_group>
    <arm_group_label>short abstinence duration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be asked to produce a second sperm sample, 2 hours after the first. This sperm will be used to inject the other half of the oocytes.
Intervention = second sperm sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>second masturbation</intervention_name>
    <description>Husbands will be asked to produce a second sperm sample in the masturbatorium</description>
    <arm_group_label>'normal' abstinence duration</arm_group_label>
    <arm_group_label>short abstinence duration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients planned for embryo development up to day 5

          -  at least 6 mature oocytes

          -  fresh ejaculates

          -  ICSI

          -  fresh embryo transfer or freeze all strategy

          -  all stimulation protocols

          -  concentration of &gt;1x10^6 /ml sperm

        Exclusion Criteria:

          -  IVF

          -  IVF versus ICSI patients

          -  chirurgical sperm

          -  acceptors of donor oocytes

          -  patients with PGD

          -  patients already enrolled in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neelke De Munck, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neelke De Munck, PhD</last_name>
    <phone>024776694</phone>
    <phone_ext>0032</phone_ext>
    <email>neelke.demunck@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ileana Mateizel, PhD</last_name>
    <phone>024749119</phone>
    <phone_ext>0032</phone_ext>
    <email>ileana.mateizel@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Neelke De Munck</investigator_full_name>
    <investigator_title>Clinical Embryologist</investigator_title>
  </responsible_party>
  <keyword>preimplantation development</keyword>
  <keyword>DNA fragmentation</keyword>
  <keyword>abstinence duration</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No data available for researchers others than the ones involved in the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

